P-004292

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameP-004292
Drug Alias NameStroke therapy - ParatekMultiple sclerosis therapy - ParatekTetracycline derivatives(Paratek Pharmaceuticals)P-004292
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of Action30S ribosomal subunit inhibitorsNeuroprotectants
Targets30S ribosomal subunit
Therapy Area/IndicationsAcne VulgarisStrokeMultiple Sclerosis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesParatek Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParatek Pharmaceutical
Active IndicationsN/A
Inactive IndicationsAcne VulgarisStrokeMultiple Sclerosis +[5] 

Other Information

ATC CodeN/A
Related LinksN/A